Most states require insurers to charge no more for a cancer pill than for an infusion, but the law does not reach the self-funded employer plans that cover most working Americans; a federal rule would close the gap.
Oral anticancer drugs are usually covered under the pharmacy benefit with coinsurance on a specialty tier, while infused drugs fall under the medical benefit with a copay. Forty-three states and the District of Columbia have parity laws, but the federal ERISA statute exempts self-funded employer plans, which cover roughly two-thirds of workers with employer coverage. The Cancer Drug Parity Act has been introduced in successive Congresses to apply parity to all plans.
Shares Financial toxicity, Prices and value.
Shares Regulatory divergence between regions, Prices and value.
Shares Financial toxicity, Prices and value.
Shares Financial toxicity, Prices and value.
Shares Financial toxicity, Prices and value.
Shares Regulatory divergence between regions, Prices and value.
Shares Regulatory divergence between regions, Prices and value.
Shares Regulatory divergence between regions, Prices and value.